Results 171 to 180 of about 2,153,086 (396)
In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. [PDF]
We present in vivo sequence-specific RNA base editing via adenosine deaminases acting on RNA (ADAR) enzymes with associated ADAR guide RNAs (adRNAs). To achieve this, we systematically engineered adRNAs to harness ADARs, and comprehensively evaluated the
Chen, Genghao+7 more
core +1 more source
Serotonin 5‐HT2C Receptor RNA Editing Alters Receptor Basal Activity [PDF]
Katharine Herrick‐Davis+2 more
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Exploring the Role in Translation Quality Control of Cytoplasmic Phenylalanyl-tRNA Synthetase [PDF]
A critical step in gene expression is the faithful translation of protein from messenger RNA. This process relies on the attachment of specifically paired amino acids to their respective tRNAs by aminoacyl-tRNA synthetases (aaRSs).
Repasky, Sarah
core
Direct Visualization of Uridylate Deletion In Vitro Suggests a Mechanism for Kinetoplastid RNA Editing [PDF]
Scott D. Seiwert+2 more
openalex +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy+9 more
wiley +1 more source
Cell type-specific loss of atp6 RNA editing in cytoplasmic male sterile Sorghum bicolor [PDF]
Werner Howad, Frank Kempken
openalex +1 more source